Home  >  Products  >  MLL4 (myeloid/lymphoid or mixed-lineage leukemia 4) Blocking Peptide (100ug)
MLL4 (myeloid/lymphoid or mixed-lineage leukemia 4) Blocking Peptide (100ug)

MLL4 (myeloid/lymphoid or mixed-lineage leukemia 4) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MLL4 antibody (Catalogue #: ARP33704_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP33704
Size: 100 ug
Weight: 64kDa
Gene: 9757
Format: Lyophilized powder
Target: MLL4 a protein which contains multiple domains including a CXXC zinc finger, three PHD zinc fingers, two FY-rich domains, and a SET (suppressor of variegation, enhancer of zeste, and trithorax) domain. The SET domain is a conserved C-terminal domain that characterizes proteins of the MLL (mixed-lineage leukemia) family. MLL4 is ubiquitously expressed in adult tissues. It is also amplified in solid tumor cell lines, and may be involved in human cancer
See Full Product Listings >